Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Guided Pipetting

By Drug Discovery Trends Editor | December 13, 2012

 

Hamilton’s Microlab 300 Series pipettor is the first guided pipetting system that brings the assurance of an automated liquid handling system into the hands of laboratory technicians without complex programming. The Microlab 300 goes beyond programming common pipetting operations like reverse pipetting and aliquoting; it enables technicians to easily create, save, and execute complete pipetting applications, achieving unsurpassed reliability through reproducible and traceable methods. 

Beyond meeting GLP/GMP, RoHS, 21 CFR Part 11, and ISO-8655 regulations, the system’s user-friendly software allows technicians to adjust pipetting parameters for superior liquid handling of challenging liquids. Through Hamilton’s validated ClickSure tips and Liquid Classes, the instrument delivers optimal pipetting accuracy by enabling users to fine-tune pipetting speeds and delays for each liquid used.

The innovative design of the Microlab 300 system replaces the three to four manual or electronic pipettes and tip sizes required for pipetting with one, lightweight Disposable Tip Hand Probe and two ClickSure tip sizes. In addition, the digital volume and speed adjustment reduces sample preparation time by eliminating manual adjustment as well as pipette exchange steps, making the Microlab 300 an efficient solution for all laboratories. 

Hamilton



Filed Under: Drug Discovery

 

Related Articles Read More >

Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE